Pelago Bioscience

Biotechnology Research • Stockholm, Stockholm County, Sweden • 51-100 Employees

Company overview

Headquarters	Pelago Bioscience AB, Scheeles väg 1, Solna, 17165, SE
Website	pelagobio.com
NAICS	541714
SIC	873
Keywords	Assay Development, Biomarkers, Drug Discovery, Fee For Service, Translational Science, Sub Licensing, Target Engagement, Cetsa, Selectivity
Founded	2013
Employees	51-100
Socials

Key Contacts at Pelago Bioscience

Michael Dabrowski

Ceo

Stephen Kosteski

Senior Director, Business Development

Marianne Alksnis

Regional Sales Director

Daniel Martinez Molina

Chief Scientific Officer, Co-Founder

Pelago Bioscience Email Formats

Pelago Bioscience uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@pelagobio.com), used 59.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@pelagobio.com	59.3%
{first initial}.{last name}	j.doe@pelagobio.com	22.2%
{first initial}	j@pelagobio.com	16.7%
{second initial}	o@pelagobio.com	1.9%

About Pelago Bioscience

At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago Bioscience has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage.Unlike traditional methods, CETSA gives you a reliable picture of drug-target interactions, ensuring that what you see in cells translates to patients. Our services rest on four pillars: • Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks. • Fast & Early Confidence: We deliver actionable insights in just 10 days-10 weeks (service dependent), eliminating unnecessary complexities so you can make decisions faster. • Insights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs. • Extended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals. With Pelago Bioscience, you gain more than just data; you gain a trusted partner in your discovery journey.

Pelago Bioscience revenue & valuation

Annual revenue	$2,401,960
Revenue per employee	$39,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,700,000
Total funding	No funding

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Pelago Bioscience has 23 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore Pelago Bioscience's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-16	1	N/A

Funding Insights

Number of funding rounds

Pelago Bioscience Tech Stack

Discover the technologies and tools that power Pelago Bioscience's digital infrastructure, from frameworks to analytics platforms.

PrestaShop

Ecommerce

WP Rocket

Caching

Goober

JavaScript libraries

Swiper

JavaScript libraries

Google Maps

Maps

One.com

Hosting

Microsoft 365

HubSpot Analytics

Analytics

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

RankMath SEO

SEO

Frequently asked questions

Pelago Bioscience is located in Stockholm, Stockholm County, SE.

Pelago Bioscience was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Pelago Bioscience has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.